本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

26.85
+0.08000.30%
成交量:12.61万
成交额:332.60万
市值:19.59亿
市盈率:-113.94
高:26.86
开:26.66
低:25.97
收:26.77
数据加载中...
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/09

SEC问询函

Form CORRESP - Correspondence
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

SEC问询函

Form CORRESP - Correspondence